BOSTON--(BUSINESS WIRE)--Women who have suffered debilitating transvaginal mesh complications following surgery to repair pelvic organ prolapse or stress urinary incontinence are urged to seek legal advice today if they have not already done so. According to Gilman Law LLP, a leading pharmacy law and defective medical device plaintiffs’ law firm that is currently representing women in transvaginal mesh lawsuits, serious settlement talks reportedly are now underway to resolve this massive litigation. Court documents indicate that more than 75,000 transvaginal mesh lawsuits have been filed in the various litigations pending in the U.S. District Court, Southern District of West Virginia and State Courts, including:
- In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2325)
- In Re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (MDL No. 2326)
- In Re: C. R. Bard, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2187)
- In Re: Coloplast Corp. Pelvic Support System Products Liability Litigation (MDL No. 2387)
- In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2440)
- In Re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2327)
- In Re: Neomedic Pelvic Repair System Products Liability Litigation (MDL No. 2511)
On June 2, 2015, the Court will convene a joint status conference, as well as individual meetings with six of the seven defendants – American Medical Systems, Boston Scientific, C.R. Bard, Coloplast, Cook Medical and Ethicon – with the goal of moving closer to resolution.
Transvaginal Mesh Settlements
Several defendants involved in the transvaginal mesh litigations have already reached settlements in a small number of claims. Most recently, Boston Scientific disclosed that it had resolved some 2,900 of the nearly 15,000 cases involving its pelvic mesh products. According to the company, the settlements will cost it around $119 million. In January, Ethicon announced that it had reached transvaginal mesh settlements in four cases for undisclosed amounts. The company still faces nearly 23,000 claims in state and federal courts. In March 2014, Coloplast entered into an agreement to settle 400 claims for a total of $16 million. C.R. Bard, which has been named as a defendant in more than 10,000 vaginal mesh lawsuits, announced last October that it had resolved about 500 claims for a total of $21 million. That same month, Endo International PLC, the parent company of American Medical Systems, reached an agreement to settle nearly all of the claims involving its pelvic mesh products for more than $400 million. In reaching these transvaginal mesh lawsuit settlements, none of the defendants have admitted any liability for patients’ alleged injuries.
The Food & Drug Administration (FDA) issued its first communication regarding the dangers associated with transvaginal mesh in October 2008, and followed up with a second public warning in July 2011. According to the FDA, transvaginal mesh complications following pelvic organ prolapse repair are not rare. What’s more, the agency also stated that it is “not clear that transvaginal POP repair with mesh is any more effective than traditional [transvaginal surgery without mesh] … and may expose patients to greater risk.” Women who have received these devices may be at risk for a number of very serious and painful complications, including:
- Mesh erosion through the vaginal tissue, possibly causing the skin to split
- Mesh extrusion and exposure.
- Perforation or puncture of bladder, intestines, bowels, and/or vaginal wall
- Protrusion or lump in the vaginal opening
- Recurrence of pelvic organ prolapse
- Recurrence of stress urinary incontinence
- Urinary problems
- Vaginal bleeding, pain and discomfort, chronic drainage, discharge, infections, scarring and/or shrinkage
- Painful sexual intercourse
Gilman Law LLP is providing complimentary lawsuit consultations to women who suffered severe complications, including tremendous pain and suffering, following implantation of transvaginal mesh. For more information, please contact Gilman Law LLP today by visiting our website, www.gilmanlawllp.com, to fill out a free, no obligation case evaluation form, or call Toll Free at 1-888-252-0048.
About Gilman Law LLP
Gilman Law LLP, a leading pharmaceutical law and defective drug law firm, has been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits. For over 35 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.